Survival analysis after surgical treatment of gastric cancer: Review of 121 cases

Hepato-Gastroenterology

Volumn 54, Issue 74, 2007, Pages 625-629

  Nazli, Okay ^a,b   Derici, Hayrullah ^a   Tansug, Tugrul ^a   Yaman, Ismail ^a   Bozdag, Ali Dogan ^a   Isgüder, Ali Serdar ^a   Bölükbasi, Hakan ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Gastric cancer; Morbidity; Mortality; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CAUSE OF DEATH; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TURKEY;

EID: 34248226762     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Thompson CB, van Herden JA, Sarr MC: Adenocarcinoma of the stomach: Are we making progress? Lancet 1993; 342:713-718.
2. Ho SB: Tumors of the stomach and small intestine. In: Friedman SL, McQuaid KR, Grendell JH (Eds.). Current diagnosis & treatment gastroenterology. 2nd Edition. New York: Mc Graw-Hill, 2003; pp. 389-406.
3. Bugra D: Influence of extended lymph node dissection on survival, morbidity and mortality in gastric cancer (review). Ulusal Cerrahi Dergisi; 1999; 15:269-281. (In Turkish with English abstract)
4. Sobin LH, Wittekind Ch (Eds.): International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 6th Edition, New York: Wiley, 2003.
5. Charles SF, Robert JM: Gastric carcinoma. N Eng J Med 1995; 6:32-41.
6. Ikeguchi M, Oka S, Gomyo Y, et al: Postoperative morbidity and mortality after gastrectomy for gastric carcinoma. Hepatogastroenterology 2001; 48:1517-1520.
7. Wang CS, Hsieh CC, Chao TC, et al: Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J 2002; 25:216-227.
8. Besisik SF: Benign and malignant tumors of the stomach and endoscopic treatment. Cerrahi Onkoloji Dergisi 2000; 1:4-7. (In Turkish with English abstract)
9. Ozenen B, Olmez M: Surgical approach towards adenocarcinoma of the stomach and survival. Cerrahi Tip Arsivi 1998; 3:48-53. (In Turkish with English abstract)
10. Cenitagoya GF, Bergh CK, Klinger-Roitman J: A prospective study of gastric cancer. 'Real' 5-year survival rates and mortality rates in a country with high incidence. Dig Surg 1998; 15:317-322.
11. Topuz E, Salepci T, Aydýner A: Chemotherapy for gastric cancer. Topuz In: E, Ayhan NF (Eds.): Cancers of the Digestive System, Ak Ofset Matbaacilik, 1998, pp. 230-242. (In Turkish)
12. Maekawa S, Saku M, Maehara Y, et al: Surgical treatment for advanced gastric cancer. Hepatogastroenterology 1996; 43:178-186.
13. Meriggi F, Forni E: Radical surgical treatment of gastric cancer. Personal experience. G Chir 2002; 23:361-367.
14. de Manzoni G, Verlato G, Guglielmi A, Laterza E; Genna M, Cordiano C: Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 83:1604-1607.
15. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993; 72:2089-2097.
16. Viste A, Svanes K, Janssen CW Jr, Maartmann-Moe H, Soreide O: Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer. Eur J Surg 1994; 160:497-502.
17. Msika S, Tazi MA, Benhamiche AM, Couillault C, Harb M, Faivre J: Population-based study of diagnosis, treatment and prognosis of gastric cancer. Br J Surg 1997; 84:1474-1478.
18. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ: Dutch Gastric Cancer Group: Value of palliative resection in gastric cancer. Br J Surg 2002; 89:1438-1443.
19. Braga M, Molinari M, Zuliani W, et al: Surgical treatment of gastric adenocarcinoma: Impact on survival and quality of life. A prospective ten year study. Hepatogastroenterology 1996; 43:187-193.
20. Shiu MH, Decosse JJ: The importance of the extent of resection for prognosis of stomach cancer patients. Scand J Gastroenterol 1987; 22:54-57.
21. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Hayashi Y, Nose Y: Prediction of survival time after curative surgery for advanced gastric cancer. Eur J Surg Oncol 1992; 18:287-292.
22. Lo SS, Wu CW, Shen KH, Hsieh MC, Lui WY: Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer. World J Surg 2002; 26:678-682.
23. Cushieri A, Fayers P, Fielding J, et al: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347:995-999.
24. Doglietto GB, Pacelli F, Caprino P, et al: Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg 1999; 65:352-355.
25. Bueono S, Marcilla G, Flores P, et al: Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998; 85:255-260.
26. Allgayer H, Heiss MM, Schildberg FW: Prognostic factors in gastric cancer. Br J Surg 1997; 84:1651-1664.
27. Spataro V, Genomi M, Maurer C, Muller W: Stomach cancer: 10 years experiences with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta 1993; 59:589-595.
28. Nakamura K, Ueyama T, Takashi Y, et al: Pathology and prognosis of gastric carcinoma. Cancer 1992; 70:1030-1037.
29. Dervisoglu A, Erzurumlu K: Prognostic factors. In: Mihmanli M (Ed.). Surgical Treatment of Gastric Cancer. Istanbul: Avrupa Tip Kitapcilik, 2004; pp. 217-224. (In Turkish)
30. Bortul M, Calligaris L, Roseano M, Leggeri A: Blood transfusions and results after curative resection for gastric cancer. Suppl Tumori 2003; 2:27-30.
31. Ruiz E, Payet C, Montalbetti JA, et al: Postoperative morbidity and in-hospital mortality of gastrectomy due to gastric adenocarcinoma: a report of 50 years. Rev Gastroenterol 2004, 24:197-210.
32. Demirci S, Eroglu A: Treatment of Gastric Cancer. Cerrahi Onkoloji Derg 2000; 1:8-21 (In Turkish with English abstract)
33. Kaneda M, Horimi T, Ninomiya M, et al: Adverse effect of blood transfusions on survival of patients with gastric cancer. Transfusion 1987; 27:375-377.